ChromaDex Corporation (CDXC)
Largest Insider Buys in Sector
CDXC Stock Price History Chart
CDXC Stock Performance
About ChromaDex Corporation
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of …
Insider Activity of ChromaDex Corporation
Over the last 12 months, insiders at ChromaDex Corporation have bought $21,397 and sold $312,066 worth of ChromaDex Corporation stock.
On average, over the past 5 years, insiders at ChromaDex Corporation have bought $73,149.23B and sold $121,915.39B worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chau Hoi Shuen Solina Holly (10 percent owner) — $365,746.17B. Pamir Ozan (Chief Financial Officer) — $42,794.
The last purchase of 2,907 shares for transaction amount of $21,397 was made by Pamir Ozan (Chief Financial Officer) on 2024‑11‑22.
List of Insider Buy and Sell Transactions, ChromaDex Corporation
| 2024-12-13 | Sale | director | 37,161 0.0488% | $6.19 | $229,956 | -1.96% | ||
| 2024-11-22 | Chief Financial Officer | 2,907.2 0.0038% | $7.36 | $21,397 | -9.81% | |||
| 2024-08-23 | Sale | director | 23,000 0.0308% | $3.57 | $82,110 | +3.28% | ||
| 2024-08-20 | Sale | 10 percent owner | 11.41M – | $32.06M | $365,746.17B | +7.19% | ||
| 2024-08-20 | 10 percent owner | 11.41M – | $32.06M | $365,746.17B | +7.19% | |||
| 2023-12-01 | Chief Financial Officer | 5,000 0.0067% | $1.41 | $7,050 | +118.44% | |||
| 2023-09-06 | 3.47M 2.9817% | $1.00 | $3.47M | +4.52% | ||||
| 2023-06-12 | director | 7,000 0.0089% | $1.69 | $11,830 | -11.30% | |||
| 2023-05-31 | Chief Executive Officer | 7,000 0.0094% | $1.42 | $9,940 | +10.64% | |||
| 2023-05-25 | director | 7,000 0.0096% | $1.46 | $10,220 | +8.39% | |||
| 2022-09-30 | 960,000 1.3206% | $1.25 | $1.2M | +29.27% | ||||
| 2022-09-30 | Cheif Executive Officer | 80,000 0.11% | $1.25 | $100,000 | +29.27% | |||
| 2022-06-16 | 60,037 0.0891% | $1.66 | $99,878 | -1.22% | ||||
| 2022-03-16 | CEO | 25,000 0.0364% | $2.16 | $54,000 | -19.35% | |||
| 2021-05-13 | CEO | 10,000 0.0147% | $6.65 | $66,500 | -9.16% | |||
| 2021-03-16 | Sale | director | 20,000 0.0316% | $13.17 | $263,400 | -48.04% | ||
| 2021-03-15 | Sale | director | 32,500 0.0477% | $11.15 | $362,375 | -42.77% | ||
| 2020-12-10 | Sale | EXECUTIVE CHAIRMAN OF BOARD | 37,829 0.0609% | $5.19 | $196,333 | +50.38% | ||
| 2020-11-06 | CHIEF FINANCIAL OFFICER | 5,000 0.008% | $4.43 | $22,150 | +75.28% | |||
| 2020-05-19 | CEO | 1,000 0.0017% | $4.69 | $4,690 | +9.12% |
Insider Historical Profitability
| Jaksch Frank L Jr | director | 244179 0.3197% | $5.49 | 11 | 8 | +3.83% |
| Pamir Ozan | Chief Financial Officer | 2907 0.0038% | $5.49 | 1 | 0 | |
| FROST PHILLIP MD ET AL | 10 percent owner | 15252937 19.9689% | $5.49 | 8 | 1 | <0.0001% |
| Champion River Ventures Ltd | 11408715 14.9361% | $5.49 | 4 | 0 | +10.25% | |
| Dvorak International Ltd | 7885641 10.3238% | $5.49 | 2 | 0 | +14.02% |
Institutional Investor Ownership
| The Vanguard Group | $10.61M | 4.04 | 3.05M | 0% | +$0 | <0.0001 | |
| Tieton Capital Management LLC | $10.52M | 4 | 3.02M | +3.71% | +$376,531.52 | 5.52 | |
| ICONIQ Capital | $4.51M | 1.72 | 1.3M | 0% | +$0 | 0.08 | |
| BlackRock | $3.14M | 1.2 | 902,953 | -0.19% | -$6,051.72 | <0.0001 | |
| Millennium Management LLC | $2.03M | 0.77 | 584,282 | +367.07% | +$1.6M | <0.01 |